Blood culture-negative infective endocarditis: are we looking hard enough?

Blood culture negative endocarditis Infective endocarditis Literature review

Journal

Infection
ISSN: 1439-0973
Titre abrégé: Infection
Pays: Germany
ID NLM: 0365307

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 01 08 2023
accepted: 07 09 2023
medline: 23 11 2023
pubmed: 4 10 2023
entrez: 4 10 2023
Statut: ppublish

Résumé

Infective endocarditis is a common cardiac condition, with significant mortality. Blood culture-negative endocarditis is an important subgroup of endocarditis that holds significant morbidity and mortality. We performed an updated review of the literature. We searched the databases of Web of Science, MEDLINE, EMBAS and Scopus for the latest clinical guidelines and literature on blood culture negative endocarditis to provide a narrative synthesis of the literature. There is significant heterogeneity in causes and complications of culture-negative infective endocarditis, due to an insensitivity in available clinical diagnostic pathways. Despite significant advances in diagnostic tools, the diagnostic criterion for infective endocarditis (the modified Duke's criterion) remains insensitive to the detection of culture-negative infective endocarditis. The natural history of BCNE and our diagnostic resources are changing. It is time our criterion did too. Remembering, BCNE holds significant morbidity and mortality-the absence of organism of culture should not reassure, rather concern clinicians. Every effort should be made to accurately identify organisms.

Identifiants

pubmed: 37792178
doi: 10.1007/s15010-023-02097-6
pii: 10.1007/s15010-023-02097-6
pmc: PMC10665218
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1629-1631

Informations de copyright

© 2023. The Author(s).

Références

Clin Med (Lond). 2020 Jul;20(4):412-416
pubmed: 32675149
Int J Gen Med. 2023 Jan 24;16:317-327
pubmed: 36718144
Eur Heart J. 2022 Aug 1;43(29):2770-2780
pubmed: 35695691
Diagn Microbiol Infect Dis. 2013 Mar;75(3):240-4
pubmed: 23318112
Front Cell Infect Microbiol. 2023 Feb 03;13:1107170
pubmed: 36816587
Heart. 2003 Mar;89(3):258-62
pubmed: 12591823
Front Cell Dev Biol. 2022 Oct 03;10:995508
pubmed: 36263017
Eur Heart J. 2015 Nov 21;36(44):3075-3128
pubmed: 26320109
J Cardiovasc Dev Dis. 2022 Jun 17;9(6):
pubmed: 35735821
Medicine (Baltimore). 2005 May;84(3):162-173
pubmed: 15879906

Auteurs

Frazer Kirk (F)

Gold Coast University Hospital, Southport, QLD, Australia. frazer.kirk@my.jcu.edu.au.
School of Medicine and Dentistry, Griffith University, Gold Coast, QLD, Australia. frazer.kirk@my.jcu.edu.au.

Natasha Marcella Vaselli (NM)

Gold Coast University Hospital, Southport, QLD, Australia.
Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
NIHR Health Protection Research Unit in Gastrointestinal Infections at the University of Liverpool, Liverpool, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH